Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112122842 | 11212284 | 2 | F | 20160727 | 20150623 | 20160729 | PER | US-PFIZER INC-2015202620 | PFIZER | 63.00 | YR | F | Y | 90.70000 | KG | 20160729 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112122842 | 11212284 | 1 | PS | LYRICA | PREGABALIN | 1 | 225 MG, 2X/DAY | 21446 | 225 | MG | CAPSULE, HARD | BID | |||||||
| 112122842 | 11212284 | 2 | SS | LYRICA | PREGABALIN | 1 | 21446 | CAPSULE, HARD | |||||||||||
| 112122842 | 11212284 | 3 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 20 MG, UNK | 0 | 20 | MG | |||||||||
| 112122842 | 11212284 | 4 | C | LORATADINE. | LORATADINE | 1 | 1 DF, DAILY | 0 | 1 | DF | |||||||||
| 112122842 | 11212284 | 5 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 88 ?G, UNK | 0 | 88 | UG | |||||||||
| 112122842 | 11212284 | 6 | C | CYCLOBENZAPRINE | CYCLOBENZAPRINE | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 112122842 | 11212284 | 7 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | 150 MG, 1X/DAY (150MG ONE TABLET BED TIME) | 0 | 150 | MG | TABLET | QD | |||||||
| 112122842 | 11212284 | 8 | C | COZAAR | LOSARTAN POTASSIUM | 1 | UNK | 0 | |||||||||||
| 112122842 | 11212284 | 9 | C | LANTUS | INSULIN GLARGINE | 1 | UNK | 0 | |||||||||||
| 112122842 | 11212284 | 10 | C | HUMALOG | INSULIN LISPRO | 1 | UNK | 0 | |||||||||||
| 112122842 | 11212284 | 11 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112122842 | 11212284 | 1 | Fibromyalgia |
| 112122842 | 11212284 | 2 | Neuropathy peripheral |
| 112122842 | 11212284 | 4 | Hypersensitivity |
| 112122842 | 11212284 | 7 | Sleep disorder |
| 112122842 | 11212284 | 8 | Hypertension |
| 112122842 | 11212284 | 9 | Diabetes mellitus |
| 112122842 | 11212284 | 10 | Diabetes mellitus |
| 112122842 | 11212284 | 11 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112122842 | 11212284 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112122842 | 11212284 | Asthenia | |
| 112122842 | 11212284 | Blood cholesterol increased | |
| 112122842 | 11212284 | Blood glucose increased | |
| 112122842 | 11212284 | Blood potassium increased | |
| 112122842 | 11212284 | Dizziness | |
| 112122842 | 11212284 | Fatigue | |
| 112122842 | 11212284 | Malaise | |
| 112122842 | 11212284 | Pain | |
| 112122842 | 11212284 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |